• Nu-Med Plus raised $450,000 in a private placement with two accredited investors on October 19, 2026.
• The investors purchased 171,232 unregistered shares of Series A Preferred Stock at $2.628 per share.
• A consultant received 50,000 unregistered shares of Series A Preferred Stock for services rendered on the same date.
• Full conversion would yield 3,424,640 common shares for investors; the consultant's shares would convert into 1,000,000 common shares, excluding beneficial ownership limits.
• The conversion ratios will not adjust for future reverse stock splits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nu-Med Plus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000709), on October 20, 2026, and is solely responsible for the information contained therein.